Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Assistance Publique-Hopitaux de Paris
InventorsPatricia Forgez, Marco Alifano
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for the treatment and the prognostic assessment of malignant pleural mesothelioma.
Claims7
A method of determining the prognosis of a subject suffering from malignant pleural mesothelioma, comprising the step of detecting the expression of neurotensin (NTS) in a mesothelioma sample obtained from said subject.
A method for the treatment of malignant pleural mesothelioma, wherein an inhibitor of the neurotensin activation of neurotensin receptor 1 (NTSR1) is administered to a subject in need thereof.
A method for the treatment of malignant pleural mesothelioma, wherein a cytotoxic agent which binds to NTSR1 is administered to a subject in need thereof.
Dependencies are inferred from the claim text.